Prot #GT-201: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of the Effects of Intravenous GC4419 on the Incidence and Duration of Severe Oral Mucositis (OM) in Patients Receiving Post-Operative or Definitive Therapy with Sing

    Project: Research project

    Project Details

    StatusActive
    Effective start/end date6/21/166/30/21

    Funding

    • Clinical Assistance Programs, LLC (Prot #GT-201)
    • Galera Therapeutics, Inc (Prot #GT-201)